A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02722954 · COMPLETED
Trial details
- NCT number
- NCT02722954
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-05-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.